Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients

Liver International

Volumn 26, Issue 1, 2006, Pages 62-72

  Solà, Ricard ^a,c   Álvarez, Marco Antonio ^b,c   Ballesté, Belén ^a,c   Montoliu, Silvia ^b,c   Rivera, Mònica ^a,c   Miquel, Mireia ^b,c   Cirera, Isabel ^a,c   Morillas, Rosa Maria ^b,c   Coll, Susanna ^a,c   Planas, Ramon ^b,c  

^a HOSPITAL DEL MAR   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Alcoholic cirrhosis; HCV related cirrhosis; Liver cancer; Natural history; Survival

Indexed keywords

ALCOHOL;

ADULT; AGE; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FATALITY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PROBABILITY; RISK FACTOR; SCORING SYSTEM;

AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; ITALY; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 33645999365     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01181.x     Document Type: Article

References (37)

1. Ascher N L, Lake J R, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20: 24S-7S.
2. Alter M J. Epidemiology of hepatitis C. Hepatology 1997; 26 (Suppl 1): 62S-5S.
3. Davis G L, Albright J E, Cook S, Rosenberg D. Projecting the future healthcare burden from hepatitis C in the United States. Hepatology 1998; 28: 390A.
4. Deuffic S, Buffat I, Poynard T, Valleron A J. Modeling the hepatitis C virus epidemic in France. Hepatology 1999; 29: 1596-601.
5. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
6. Forns X, Ampurdanès S, Sánchez-Tapias J M, Guilera M, Sans M, Sanchez-Fueyo A, et al. Long term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol 2001; 35: 265-71.
7. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterolgy 1997; 112: 463-72.
8. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-801.
9. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrosis. N Engl J Med 1991; 325: 675-80.
10. Ginès P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987; 7: 122-8.
11. Maddrey W C, Boitnott J K, Bedine M S, Weber F L, Mezey E, White R I. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-9.
12. Rimola A, Bory F, Planas R, Xaubet A, Bruguera M, Rodés J. Infecciones bacterianas en la cirrosis hepática. Gastroenterol Hepatol 1981; 4: 453-8.
13. Caly W R, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18: 353-8.
14. Schlichting P, Christensen E, Fauerholdt L, Poulsen H, Juhl E, Tygstrup N. Main causes of death in cirrhosis. Scand J Gastroenterol 1983; 18: 891-8.
15. Rimola A, García-Taso G, Navasa M, Piddock L J, Planas R, Bernanrd B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document. J Hepatol 2000; 32: 142-53.
16. Planas R, Boix J, Broggi M, Cabre E, Gomes-Vieira, Morillas R, et al. Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1991; 100: 1078-86.
17. de Franchis R. Updating consensus in portal hypertension: Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-52.
18. Bruix J, Sherman M, Llovet J M, Beaugrand M, Lencioni R, Burroughs A K, et al. for the EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35: 421-30.
19. Seeff L B. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-46S.
20. Cabré E, Rodríguez-Iglesias P, Caballería J, Quer J C, Sánchez-Lombrana J L, Parés A, et al. on behalf of the Spanish Group for the Study of Alcoholic Hepatitis. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial. Hepatology 2000; 32: 36-42.
21. Degos F, Christidis C, Ganne-Carrié N, Farmachidi J P, Degott C, Guettier C, et al. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death. Gut 2000; 47: 131-6.
22. Velázquez R F, Rodríguez M, Navascués C A, Linares A, Perez R, Sotorrios R G, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003; 37: 520-7.
23. Resnick R H, Koff R. Hepatitis C-related hepatocarcinoma. Prevalence and significance. Arch Intern Med 1993; 153: 1672-7.
24. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: A prospective study on the incidence and hierarchy of major complications. Gut 2004; 53: 744-9.
25. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Semin Liver Dis 1999; 19: 263-9.
26. Chiba T, Matsuzaki Y, Abei M, Shoda J, Aikawa T, Tanaka N, et al. Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. J Gastroenterol 1996; 31: 552-8.
27. Miyakawa H, Izumi N, Marumo F, Sato C. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis. Alcohol Clin Exp Res 1996; 20 (Suppl 1): 91A-4A.
28. Simonetti R G, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97-102.
29. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325: 829-35.
30. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9.
31. Moore K P, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: Report of the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-66.
32. McCormick P A, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49: 682-5.
33. D'Amico G, De Franchis R and a Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.
34. Bernard B, Grange J D, Khac E, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis. Hepatology 1999; 29: 1655-61.
35. Soterakis J, Resnick R H, Iber F L. Effect of alcohol abstinence on survival in cirrhotic portal hypertension. Lancet 1973; 2: 65-7.
36. Orrego H, Blake J E, Blendis L M, Kapur B M, Israel Y. Reliability of assessment of alcohol intake based on personal interviews in a liver clinic. Lancet 1979; 2: 1354-6.
37. Imazeki F, Yokosuka O, Fukai K, Saisho H. Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study. Hepatology 2003; 38: 493-502.